All the countries agreed to the treatment target of 15 million people living with HIV on antiretroviral treatment by 2015. See para 66.
IP and Access to Medicines
TRIPS is covered in para 34, 35, 36, 71 and 72 of the declaration. The term “TRIPS+” has been removed from the final declaration after negotiations between India, Brazil, Thailand and South Africa on one side and the US, EU, Japan and Switzerland on the other side.
Para 71 has a clear commitment to “remove” IP obstacles which limit the capacity of low- and middle-income countries to provide affordable and effective HIV prevention and treatment products, diagnostics, medicines and commodities and other pharmaceutical products.
The sub-paras of para 71 refer to “full use” of TRIPS flexibilities, removal of regulations, policies and practices that prevent access to affordable HIV treatment and encouraging use of mechanisms such as partnerships, tiered pricing, open-source sharing of patents and patent pools.
International organisations including the World Intellectual Property Organization, the United Nations Industrial Development Organization, the United Nations Development Programme, the United Nations Conference on Trade and Development, the World Trade Organization and the World Health Organization have been called upon to provide technical assistance and capacity building including on use of TRIPS flexibilities to the governments of the developing countries.